| 1641/1816 | US=61 / Câncer Siddik ZH. Biochemical resistance: cisplatin resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 283-307. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CISPLATINA; RESISTENCIA; MECANISMO MOLECULAR; ADUTOS DE DNA; RECONHECIMENTO DE DANOS; DNA DE TOLERANCIA AO DANO; CICLO CELULAR; APOPTOSE |
| 1642/1816 | US=61 / Câncer Safaei R, Howell SB. Biochemical resistance: regulation of the cellular pharmacology and cytotoxicity of cisplatin by copper transporters. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 309-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CISPLATINA; COBRE; COBRE TRANSPORTADORES METALICOS COMPLEXOS METALLOTRANS PORTEIROS |
| 1643/1816 | US=61 / Câncer Greenberger LM, Sampath D. Biochemical resistance: resistance to taxanes. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 329-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. TAXANOS; RESISTENCIA; MICROTUBULOS; TUBULIN; TRANSPORTADORES; P-GLICOPROTEINA; APOPTOSE; TRANSDUCAO DE SINAL |
| 1644/1816 | US=61 / Câncer Teodoridis JM, Brown R. Biochemical resistance: CpG island methylation and drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 359-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 1645/1816 | US=61 / Câncer Hazlehurst LA, Dalton WS. Biochemical resistance: de novo and acquired resistance to antitumor alkylating agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 377-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. AGENTES ALQUILANTES ANTITUMORAIS; DE NOVO A RESISTENCIA; RESISTENCIA ADQUIRIDA; GLUTATIONA; GLUTATIONA-S-TRANSFERASE; FANCONI ANEMIA/BRCA1 CAMINHO |
| 1646/1816 | US=61 / Câncer Sledge Junior GW, Miller KD, Schneider B, Sweeney CJ. Biochemical resistance: resistance to to antiangiogenic agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 391-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIANGIOGENESIS; FACTORES DE CRESCIMENTO ENDOTELIAIS VASCULARES; RECEPTOR DO FATOR ENDOTELIAL VASCULAR; HIPOXIA; INIBIDORES DA TIROSINA QUINASE |
| 1647/1816 | US=61 / Câncer osipo C, O'Regan RM. The role of hormones, growth factors, and oncogenes: resistance to antiestrogens. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 411-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIESTROGENEO; RESISTENCIA; TAMOXIFEN; CANCER DE MAMA; RECEPTOR DE ESTROGENO; INIBIDORES DE AROMATASE; FACTORES DE CRESCIMENTO |
| 1648/1816 | US=61 / Câncer Gandhi V, Sanchez-Vega B. The role of hormones, growth factors, and oncogenes: mechanisms of glucocorticoid actions and resistance in multiple myeloma. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 435-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. GLICOCORTICOIDES; RESISTENCIA; PROTEINA RECEPTORA; APOPTOSE; MIELOMA; ISOFORMAS; POSTAR MODIFICACAO DE TRANSLACAO |
| 1649/1816 | US=61 / Câncer Mayer IA, Arteaga CL. The role of hormones, growth factors, and oncogenes: herceptin resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 459-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. HERCEPTIN; RECEPTOR DE ESTROGENO; RECEPTOR DO FATOR DE CRESCIMENTO EPITELIAL; HER-2; ERB2 |
| 1650/1816 | US=61 / Câncer Pinkas J, Teicher BA. The role of hormones, growth factors, and oncogenes: role of TGF-b in tumor progression and metastasis. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 469-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. FATOR DE CRESCIMENTO TRANSFORMANTE-B; RECEPTOR DO FATOR DE CRESCIMENTO TRANSFORMANTE-B; SMAD; OSTEOCLASTOS; FIBROSE |
| 1651/1816 | US=61 / Câncer DeLeo AB. The role of hormones, growth factors, and oncogenes: p53-based immunotherapy of cancer. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 491-505. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 1652/1816 | US=61 / Câncer Dent P, Yacoub A, Hagan MP, Grant S. The role of hormones, growth factors, and oncogenes: response and resistance to ionizing radiation. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 507-29. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. RADIACAO; SINALIZACAO; QUINASE; FOSFATASE; OXIGENIO / NITROGENIO REATIVO; ESPECIES; RECEPTOR |
| 1653/1816 | US=61 / Câncer Yen MJ, Shih LM, Velculescu VE, Wang TL. The role of hormones, growth factors, and oncogenes: amplification in DNA copy numbers as a mechanism of acquired drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 531-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. AMPLIFICACAO; RESISTENCIA AS DROGAS; INSTABILIDADE CROMOSSOMICA; HIBRIDACAO IN SITU FLUORESCENTE; HIBRIDIZACAO GENOMICA COMPARATIVA; CARIOTIPO DIGITAIS |
| 1654/1816 | US=61 / Câncer Sovak MA, Spriggs DR. Clinical aspects of resistance: cancer chemotherapy. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 541-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. RESISTENCIA AS DROGAS CLINICA; BIOMARCADORES; CRITERIOS DE RESPOSTA; QUIMIOTERAPIA COMBINADA; MARCADORES SUBSTITUTOS |
| 1655/1816 | US=61 / Câncer Kee K, Green JE. Clinical aspects of resistance: molecular profiling in breast cancer. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 559-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CANCER DE MAMA; PERFIL DE EXPRESSAO DO GENE; MICROARRAY; ANALISE DA SEQUENCIA DE OLIGONUCLEOTIDO MATRIZ; GENOMICA; ALVOS TERAPEUTICOS |
| 1656/1816 | US=61 / Câncer Koh YT, García-Hernández ML, Kast WM. Clinical aspects of resistance: tumor immune escape mechanisms. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 577-602. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. IMUNOVIGILANCIA; IMUNOGENICIDADE; MECANISMOS DE ESCAPE; ANTIGENIOS TUMORAIS; IMUNODETECCAO; MICROAMBIENTE TUMORAL |
| 1657/1816 | US=7 / Dermatologia Trindade Neto PB, Azulay DR, Azulay RD. Dermatozoonoses. In: Azulay RD, Azulay DR, Azulay-Abulafia L. Dermatologia. 5ªed. Rio de Janeiro: Guanabara Koogan, 2006. p. 438-52. ISBN 85-2771433-4. DERMATOZOONOSES; ZOODERMATOSES; ESCABIOSES; SARCOPTIDIASES; ESCABIOSE HUMANA; SARNA CROSTOSA; SARNAS ZOOGENAS; DEMODECIDOSE; PEDICULOSE; DERMATITE VESICANTE POR PAEDERUS; DIPTERIASES; MIIASES; LARVA MIGRANS; PULICOSE; TUNGIASE; IXODIDIASE; DOENCA DE LYMEONCOCERCOSES; CEGUEIRA DOS RIOS; CIMIDIASE; TRIATOMIDIASE |
| 1658/1816 | US=7 / Ortopedia Lewandrowski KU, Bell GR, McLain RF. Cancer of the spine: how big is the problem?. In: McLain RF. Cancer in the spine: comprehensive care. New Jersey: Humana Press, 2006. p. 1-5. (Current Clinical Oncology) ISBN 978-1-58829-074-3. CANCER DA COLUNA; ESTATISTICA; CANCER DE COLUNA. EPIDEMIOLOGIA; METASTASE |
| 1659/1816 | US=7 / Ortopedia Hicks DG. Metastatic disease to the musculoskeletal system. In: McLain RF. Cancer in the spine: comprehensive care. New Jersey: Humana Press, 2006. p. 7-16. (Current Clinical Oncology) ISBN 978-1-58829-074-3. CANCER DA COLUNA; DOENCA METASTATICA; METASTASE; SISTEMA MUSCULO-ESQUELETICO; CANCER DE MAMA; CANCER DE PROSTATA; BIOLOGIA DE REMODELACAO OSSEA; ADESAO CELULAR; INVASAO CELULAR |
| 1660/1816 | US=7 / Ortopedia Togawa D, Lewandrowski KU. The pathophysiology of spinal metastases. In: McLain RF. Cancer in the spine: comprehensive care. New Jersey: Humana Press, 2006. p. 17-23. (Current Clinical Oncology) ISBN 978-1-58829-074-3. CANCER DA COLUNA; METASTASE; COLUNA VERTEBRAL. FISIOPATOLOGIA |